CorMedix (CRMD) Gross Profit (2013 - 2025)

CorMedix has disclosed Gross Profit across 12 years of filings, most recently posting $107.3 million for Q4 2025.

• Gross Profit for Q4 2025 came in at $107.3 million, up 257.28% year-over-year; the trailing twelve-month figure through Dec 2025 was $275.7 million (up 584.54% YoY), and the FY2025 annual result was $275.7 million, up 584.54% from the prior year.
• Gross Profit came in at $107.3 million for Q4 2025 at CorMedix, up from $93.1 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $107.3 million in Q4 2025 to a low of -$818539.0 in Q1 2024.
• The 4-year median for Gross Profit is $28109.0 (2021), against an average of $19.8 million.
• Across the five-year window, Gross Profit plunged 127.47% in 2021 and soared 12683.29% in 2025, its largest moves.
• CorMedix's Gross Profit stood at $8390.0 in 2021, then surged by 249.18% to $29296.0 in 2022, then soared by 102421.64% to $30.0 million in 2024, then surged by 257.28% to $107.3 million in 2025.
• The last three Gross Profit figures came in at $107.3 million (Q4 2025), $93.1 million (Q3 2025), and $37.9 million (Q2 2025), per Business Quant data.